Affiliation:
1. NATIONAL MEDICAL UNIVERSITY, KHARKIV, UKRAINE
Abstract
The aim: To optimize the differential diagnosis of bacterial pneumonia and tuberculosis in HIV-positive patients based on the value of serum seromucoid.
Materials and methods: The study included 77 HIV-positive patients with lung pathology. The 1st group consisted of 44 HIV-infected patients with BP; the 2nd group – of 33 patients with HIV/TB co-infection. Level of SSM, CD4+ T-lymphocytes, HIV-1 RNA viral load was determined. Сlinical, laboratory, microscopic, radiological, microbiological, and statistical methods were used in the research.
Results: In patients with HIV/TB co-infection CD4+ T-lymphocyte level was lower, and viral load was higher than in HIV-infected patients with BP. The level of SSM was statistically significantly elevated in patients of both groups compared with the control (p<0,001), but in patients with HIV/TB co-infection the values were statistically significantly higher (p<0,001). In patients with BP, the content of SSM≤15,95 TU occurred statistically significantly more often than in patients with TB (χ2= 65,5; p <0,001). No statistically significant relationship between SSM content and CD4+ T-lymphocyte levels was found.
Conclusions: The content of SSM in patients with HIV/TB co-infection is statistically significantly higher than in the group of HIV-infected patients with BP. Determination of SSM level can be used as a rapid method of differential diagnosis of BP and TB in HIV-positive patients that will allow to optimize the diagnostic algorithm at the early stage of hospitalization and to receive the necessary timely treatment for HIV-infected patients.
Reference19 articles.
1. 1. Pillay Y., Johnson L. World AIDS Day 2020: Reflections on global and South African progress and continuing challenges. Southern African Journal of HIV Medicine. 2021; 22: 1-5. doi:10.4102/sajhivmed. v22i1.1205.
2. 2. HIV infection in Ukraine: Information bulletin of the Ministry of Health of Ukraine № 52. Kyiv. 2021; 52:16. ( In Ukrainian).
3. 3. Hvozdetska M., Kozko V., Yurko K. et al. Factors affecting the fatal outcome in HIV-infected patients with encephalitis. Georgian medical news. 2018; 7-8 (280-281):85-89.
4. 4. Liskina I.V., Melnyk O.O., Zagaba L.M. et al. Morfolohichna diahnostyka infektsiinykh urazhen sered VIL-infikovanykh patsiientiv z patolohiieiu orhaniv hrudnoi porozhnyny. Zdobutky klinichnoi i eksperymentalnoi medytsyny [Morphological diagnosis of infectious lesions among HIV-infected patients with pathology of the thoracic cavity]. Achievements of clinical and experimental medicine. 2020; 3:126-134. (In Ukrainian).
5. 5. Belosludtseva K.O. Osoblyvosti tiazhkykh nehospitalnykh pnevmonii u VIL-infikovanykh khvorykh. [Features of severe community-acquired pneumonia in HIV-infected patients]. Clinical medicine. 2014; 19(2):53- 60. (In Ukrainian).